Constellation Brands, Inc. (STZ) Stock Price & Analysis
Constellation Brands, Inc. (STZ) closed at USD 138.98 on Thursday, October 22, 2026, up 5.27% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 132.02; the Oct 22, 2026 session ranged USD 132.67–139.31 on volume of 2,494,396 shares. Market capitalization is $23.52B, with a 52-week range of USD 110.6–168.6 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:26 UTC.
Also available as compact Markdown for AI agents: nexqual.com/STZ.md
Key facts (STZ)
- Last four reported quarters (through Aug 31, 2026): revenue $9.21B, net income $1.92B (20.9% margin), free cash flow $1.84B (SEC filings).
- Valuation: P/E 12.2x, EV/EBITDA 10.5x, net debt $10.1B.
- 4 of 80 tracked superinvestors hold STZ (13F, Q2 2026 (1 investor on Q3 2026, filed early)): 0 new, 2 added, 2 reduced, 0 unchanged.
- Analysts: Buy (mean 2.46 on a 1–5 scale) (24 analysts), mean target USD 150.87 (range 99–209).
- Total return with dividends: 1Y +2.4% vs S&P 500 +14.9%; 5Y -30.5% vs S&P 500 +80.3%.
- Next earnings: 2026-10-06, EPS estimate USD 2.72, revenue estimate $2.18B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (STZ)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $8.82B | $9.45B | $9.96B | $10.2B | $9.14B | $9.21B |
| Gross profit | $4.71B | $4.77B | $5.02B | $5.31B | $4.71B | — |
| Operating income | $2.33B | $2.84B | $3.17B | $355M | $2.72B | $2.78B |
| Net income | -$40.4M | -$71.0M | $1.73B | -$81.4M | $1.69B | $1.92B |
| Free cash flow | $1.68B | $1.72B | $1.51B | $1.94B | $1.79B | $1.84B |
| Gross margin | 53.4% | 50.5% | 50.4% | 52.1% | 51.6% | — |
| Operating margin | 26.4% | 30.1% | 31.8% | 3.5% | 29.8% | 30.2% |
| Net margin | -0.5% | -0.8% | 17.3% | -0.8% | 18.5% | 20.9% |
| Revenue growth | +2.4% | +7.2% | +5.4% | +2.5% | -10.5% | — |
| Cash + short-term investments | $199M | $134M | $152M | $68.1M | $102M | — |
| Total debt | $10.1B | $11.3B | $11.6B | $10.7B | $10.3B | — |
Fiscal years end Feb. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Aug 31, 2026) (STZ)
P/E 12.2x · P/S 2.5x · EV/EBITDA 10.5x · EV/Sales 3.6x · P/FCF 12.8x · P/B 2.7x · FCF yield 7.82% · Earnings yield 8.18% · Dividend yield (paid, TTM) 3.01% · Buyback yield (TTM) 3.29% · Net debt $10.1B · EV $33.6B
Superinvestors (SEC 13F-HR, Q2 2026) (STZ)
4 of 80 tracked investors hold STZ (1 investor on Q3 2026, filed early). Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change | Quarter |
|---|---|---|---|---|---|
| Hillman Capital | Hillman Capital Management | 1.58% | $2.2M | Reduced -16.7% | Q2 2026 |
| David Katz | Matrix Asset Advisors | 0.84% | $10.2M | Added +21.2% | Q3 2026 |
| Bill Nygren | Oakmark Funds | 0.57% | $431M | Reduced -4.2% | Q2 2026 |
| Richard Pzena | Pzena Investment Management | 0.24% | $83.4M | Added +0.6% | Q2 2026 |
Analysts (STZ)
Consensus Buy (mean 2.46 on a 1–5 scale), 24 analysts; mean target USD 150.87 (low 99, high 209).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-08 | JP Morgan | Target raised | Neutral | $133 → $136 |
| 2026-10-08 | Freedom Broker | Upgrade | Hold → Buy | $173 → $158 |
| 2026-10-08 | UBS | Target lowered | Buy | $145 → $144 |
| 2026-10-08 | Piper Sandler | Target lowered | Neutral | $161 → $125 |
| 2026-10-08 | Deutsche Bank | Target lowered | Hold | $136 → $127 |
| 2026-10-08 | RBC Capital | Target lowered | Outperform | $185 → $182 |
| 2026-10-08 | Needham | Target lowered | Buy | $185 → $150 |
| 2026-10-08 | Morgan Stanley | Target lowered | Equal-Weight | $158 → $145 |
| 2026-10-08 | HSBC | Downgrade | Buy → Hold | $192 → $135 |
| 2026-10-05 | Wells Fargo | Target lowered | Overweight | $170 → $140 |
| 2026-10-02 | RBC Capital | Reiterated | Outperform | $185 |
| 2026-09-25 | JP Morgan | Target lowered | Neutral | $165 → $133 |
Total return (dividends reinvested) (STZ)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +2.4% | -30.5% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +2.4% | -7.0% |
| Volatility (annualized) | 31.0% | 25.9% |
| Max drawdown | -31.4% (Feb 2026→Sep 2026) | -56.0% (Mar 2024→Sep 2026) |
Companies that name STZ in their SEC reports
| Relationship to STZ | Company | Filing | Sentence |
|---|---|---|---|
| customer | IP STRATEGY HOLDINGS, INC. (IPST) | 10-K Apr 14, 2026 | “In the United States, spirits sales are relatively concentrated among a limited number of large suppliers, including Diageo plc (NYSE: DEO), Pernod Ricard SA, E & J Gallo Winery, Proximo Spirits, Sazerac Company, MGP, and Constellation Brands, Inc. (NYSE: STZ), among others.” |
STZ analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Nov 2026) | $2.72 | $2.85 | -4.3% | $2.18B | 19 |
| Next quarter (ends Feb 2027) | $1.93 | $1.91 | +1.1% | $1.87B | 19 |
| Current fiscal year (ends Feb 2027) | $11.82 | $11.79 | +0.2% | $9.12B | 24 |
| Next fiscal year (ends Feb 2028) | $12.10 | $12.37 | -2.2% | $9.25B | 23 |
Key Statistics (as of October 23, 2026 at 09:26 UTC)
| Price | USD 138.98 |
|---|---|
| Change | ▲ 5.27% (up) |
| Previous Close | USD 132.02 |
| Open | USD 133.31 |
| Day Range | USD 132.67 – 139.31 |
| 52-Week Range | USD 110.6 – 168.6 |
| Volume | 2,494,396 shares |
| Market Cap | $23.52B |
| Exchange | NYQ |
Technical Analysis (STZ)
Nexqual's technical model rates STZ "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of October 23, 2026 at 09:26 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 75.41 (overbought) |
| vs SMA50 | Above (USD 125.49) |
| MACD | 3.36 (positive) |
Analyst Ratings (STZ)
Wall Street analysts rate STZ "Buy" based on 24 analysts, with a mean price target of USD 150.87 (range USD 99–209), per Nexqual as of October 23, 2026 at 09:26 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 24 |
| Mean Target | USD 150.87 |
| High Target | USD 209 |
| Low Target | USD 99 |
| Buy / Hold / Sell | 14 / 8 / 2 |
Earnings (STZ)
| Next Earnings Date | 2026-10-06 |
|---|---|
| EPS Estimate | USD 2.72 |
| Revenue Estimate | $2.18B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-08-31 | USD 3.74 vs est 3.55 ▲ beat |
| 2026-05-31 | USD 3.43 vs est 3.2 ▲ beat |
| 2026-02-28 | USD 1.9 vs est 1.71 ▲ beat |
| 2025-11-30 | USD 3.06 vs est 2.63 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financials & Fundamentals (STZ)
| Total Revenue | $9.21B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +6.10% |
| Gross Margin | +52.77% |
| Operating Margin | +33.58% |
| Profit Margin | +20.89% |
| ROE | +24.01% |
| Debt / Equity | 1.16 |
| Current Ratio | 1 |
| Total Cash | $98.50M |
| Total Debt | $10.32B |
| Free Cash Flow (last four quarters to Aug 2026, SEC 10-Q / 10-K) | $1.84B (20.0% of revenue) |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financial Health Score (STZ)
Nexqual rates Constellation Brands, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:26 UTC.
| Growth | Critical — Revenue -10% YoY (annual), sharp decline |
|---|---|
| Profitability | Strong — Gross margin 53%, operating 34% (last 12 months) |
| Balance Sheet | Weak — $99M cash and investments vs $10.2B debt (Aug 2026, SEC) |
| Cash Flow | Strong — FCF $1.84B (last 4 quarters to Aug 2026, SEC), 20% margin |
| Efficiency | Strong — ROE 24%, ROA 8.7% |
Ownership (STZ)
| Insider Ownership | +12.68% |
|---|---|
| Institutional Ownership | +89.66% |
| Shares Outstanding | 169.20M |
| Float | 156.25M |
| Short % of Float | +6.50% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Leadership (STZ)
Constellation Brands, Inc. is led by Nicholas Ian Fink, President, CEO & Director, per Nexqual as of October 23, 2026 at 09:26 UTC.
| President, CEO & Director | Nicholas Ian Fink |
|---|---|
| Executive VP & CFO | Garth Hankinson |
| Executive VP & President of Beer Division | James A. Sabia |
| Executive VP & President of Wine & Spirits Division | Samuel James Glaetzer |
| Vice President of Investor Relations | Blair Veenema |
Major Backers & Investors (STZ)
Notable institutional backers of Constellation Brands, Inc. include Capital Group, FMR, LLC, Grantham, Mayo, Van Otterloo & Co. LLC, according to Nexqual as of October 23, 2026 at 09:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Capital Group | 6.62% |
| FMR, LLC | 2.72% |
| Grantham, Mayo, Van Otterloo & Co. LLC | 2.36% |
| Wellington Management | 2.26% |
| WASHINGTON MUTUAL INVESTORS FUND | 2.12% |
| AMERICAN BALANCED FUND | 2.1% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 10.15% |
| BlackRock | 6.82% |
| State Street | 4.01% |
| Geode Capital | 2.26% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FMX | Fomento Economico Mexicano S.A. | USD 129.03 | ▲ 0.82% |
| ABEV | Ambev S.A. | USD 3.33 | ▲ 1.83% |
| TAP-A | Molson Coors Beverage Company | USD 42.54 | ▼ 8.93% |
| BUD | Anheuser-Busch Inbev SA Sponsor | USD 85.49 | ▲ 3.89% |
| SAM | Boston Beer Company, Inc. (The) | USD 195.72 | ▲ 7.65% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:26 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt